Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: An historical cohort study

Breast Cancer Research and Treatment

Volumn 76, Issue 2, 2002, Pages 137-143

  Lesperance, M L ^a   Olivotto, I A ^b   Forde, N ^c   Zhao, Y ^d   Speers, C ^b   Foster, H ^a   Tsao, M ^a   MacPherson, N ^b   Hoffer, A ^e  

^a UNIVERSITY OF VICTORIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d UNIVERSITY OF WATERLOO   (Canada)

^e British Columbia Cancer Agency ^*  (Canada)

Author keywords

Breast cancer; Complementary therapy; Historical cohort study; Minerals; Survival; Vitamins

Indexed keywords

ANTINEOPLASTIC AGENT; ASCORBIC ACID; BETA CAROTENE; ESTROGEN RECEPTOR; MINERAL; NICOTINIC ACID; TAMOXIFEN; UBIDECARENONE; VITAMIN; ZINC;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

BREAST NEOPLASMS; BRITISH COLUMBIA; COHORT STUDIES; COMBINED MODALITY THERAPY; COMPLEMENTARY THERAPIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; MINERALS; SURVIVAL ANALYSIS; VITAMINS;

EID: 0036829608     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020552501345     Document Type: Article

References (17)

1. Tagliaferri M, Cohen I, Tripathy D: Complementary and alternative medicine in early-stage breast cancer. Semin Oncol 28: 121-134, 2001
2. Morris KT, Johnson N, Homer L, Walts D: A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Amer J Surg 179: 407-411, 2000
3. Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, McWilliam C, Gavin A, Baron RA, Aaron D, Haines-Kamka T: Use of complementary/alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions. J Clin Oncol 18: 2515-2521, 2000
4. Jacobson JS, Workman SB, Kronenber F: Research on complementary/alternative medicine for patients with breast cancer: A review of the biomedical literature. J Clin Oncol 18: 668-683, 2000
5. Sobin LH, Wittekind CH (eds): TNM Classification of Malignant Tumours. 5th Edn, Wiley, New York, 1997, pp 121-130
6. Elston CW, Willis IO: Pathological prognostic factors in breast cancer: The value of histological grade in breast cancer - Experience from a large study with long-term follow-up. Histopathology 19: 403-410, 1991
7. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. Wiley, New York, 1980
8. Klein JP, Moeschberger ML: Survival Analysis: Techniques for Censored and Truncated Data. Springer-Verlag, New York, 1997
9. Therneau T, Grambsch P: Modeling Survival Data: Extending the Cox Model 2000. Springer-Verlag, New York
10. Olivotto IA, Coldman AJ, Hislop TG, Trevisan CH, Kula J, Goel V, Sawka C: Compliance with practice guidelines for node-negative breast cancer. J Clinic Oncol 15: 216-222, 1997
11. Wright S, Monro J, Payne M, James N, Reed A: Bristol Cancer Help Centre. Lancet 336: 743-744, 1990
12. Bagenal FS, Easton DF, Harris E et al.: Survival of patients with breast cancer attending Bristol Cancer Help Centre. Lancet 336: 606-610, 1990
13. Hoffer A, Pauling L: Hardin Jones biostatistical analysis of mortality data for a second set of cohorts of cancer patients with a large fraction surviving at the termination of the study and a comparison of survival times of cancer patients receiving large regular doses of vitamin C and other nutrients with similar patients not receiving these doses. J Orthomol Med 8: 157-167, 1993
14. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirex AJ: Influence of delay on survival in patients with breast cancer: A systematic review. Lancet 353: 1119-1126, 1999
15. Fisher B, Anderson S, Redmond C, Wolmark N, Wickerham DL, Cronin WM: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. New England J Med 333: 1456-1461, 1995
16. Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, Lipa M, Wilkinson RH, Mahoney LJ: Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update. J Natl Cancer Inst 88: 1659-1664, 1996
17. Siegel BS: Love, Medicine and Miracles. Arrow Books, London, 1988